What Elevate Clinical Research does

Elevate Clinical Research, Inc. is a private, Delaware-incorporated site management organization (SMO) founded in 2024 and headquartered in Fort Worth, Texas. The company operates a growing network of clinical research sites across the United States — including owned locations in Houston, McAllen, Lake Charles, Gurnee, Rockville, and Wichita; joint-venture sites Elevate Synapsis (Atascocita, TX, with Synapsis Bio) and Elevate Up (Waxahachie, TX, with Dallas Neurology Care Clinic); and a decentralized division that reaches patients in 48 states through Dr. Kinjal Desai. Elevate runs trials from Phase 1b through Phase 4 across therapeutic areas including neurology, psychiatry, gastroenterology, cardiovascular/metabolic/renal, endocrinology, pulmonology, ophthalmology, women's health, family medicine, and infectious disease/vaccines.

The company's core technology stack is built around its membership in CRIO's Partners Program (joined July 2024), through which Elevate provides same-day EDC data entry (with most site visits entered overnight and 60-90% of queries resolved same-day), eRegulatory and eISF document management, and multi-channel patient recruitment with rigorous pre-screening to lower screen-fail rates. There is no proprietary AI or ML layer disclosed; all automation and workflow tooling is layered on top of the CRIO platform. Elevate holds HIPAA-compliant operational policies and runs specialized facilities, notably the 28-room Synapsis Phase 1b-capable site.

Elevate's revenue model has two distinct streams: (1) Clinical Trial Services, where the company is compensated on a transaction-fee basis for conducting trials and enrolling patients on behalf of pharmaceutical sponsors and CROs; and (2) Site Partner Services, a managed-services offering (business development, finance, regulatory, data entry, and recruitment) sold to existing independent research sites that join the Elevate network in exchange for fees. The company is sales-led with channel-partner distribution through its site partner network, and reaches patients via content marketing, social media, industry events, and direct outreach. As of the available data, the company has filed an SEC Form D for a minimum $1M equity raise (June 2025) and operates with a small central team (1-10 employees listed) while scaling across multiple geographies.

Name

Elevate Clinical Research

Legal name

Elevate Clinical Research, Inc.

Website

https://elevateclinical.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Elevate Clinical Research is a private site management organization operating a multi-state US network of clinical research sites and decentralized trials, conducting Phase 1b-4 studies across multiple therapeutic areas for pharmaceutical sponsors, CROs, and partner sites.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)

Keywords

• Clinical trial management
• Site management organization
• Patient recruitment services
• Clinical research services
• Clinical trial conduct

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices10 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Trial Services: Revenue generated from conducting clinical trials for pharmaceutical sponsors and CROs. The company operates clinical research sites and provides site management services, receiving compensation for each trial conducted and patient enrolled.
2. Site Partner Services: Business development, operational support, financial management, regulatory compliance, data entry, and patient recruitment services provided to partner research sites in exchange for fees.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Elevate Clinical Research is a site management organization that operates a network of clinical research sites across the United States, conducting Phase 1 through Phase 4 trials in multiple therapeutic areas for pharmaceutical sponsors and CROs. The company also provides site partner services—business development, operational support, regulatory management, patient recruitment, and data entry services—to existing clinical research sites that join its network. Its portfolio includes owned sites, joint venture sites with specialist physicians, and decentralized trial operations.

Product overview

Elevate Clinical Research is a full-service clinical research site management organization that operates a network of clinical trial sites across the United States. The company provides core site management services including patient recruitment, data entry management, regulatory management, and operational support for sponsors and CROs. Their portfolio includes both owned research sites (Houston, McAllen, Lake Charles, Gurnee, Rockville, Wichita) and joint venture sites (Elevate Synapsis in Atascocita, TX and Elevate Up in Waxahachie, TX), as well as a decentralized trials division operating nationwide. The company also offers site partner services including business development, finance support, and recruitment services for clinical research sites joining their network.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Site Management Services Full-service clinical trial conduct for pharmaceutical sponsors and CROs across multiple therapeutic areas, including patient recruitment, site management, regulatory compliance, data entry, and operational support delivered through Elevate's network of research sites.
• Elevate Decentralized Decentralized clinical research service that operates without a fixed physical location and remotely connects with patients across 48 states to conduct trials and reach broad, diverse populations.
• Site Partner Services Business development, budget negotiation, operational support, financial management, regulatory management, data entry management, and patient recruitment services provided to existing clinical research sites that join Elevate's site network.
• Elevate Synapsis - Atascocita, TX Joint venture with Synapsis Bio featuring 28 rooms for Phase 1b through Phase 4 clinical trials with both inpatient and outpatient capabilities, led by Dr. Matthew Brams, a board-certified psychiatrist with over 26 years of experience and over 300 clinical trials conducted.
• Elevate Up - Waxahachie, TX Joint venture with Dallas Neurology Care Clinic in Waxahachie, Texas, focused on neurology clinical trials and led by Dr. Khalid, a board-certified neurologist specializing in diagnosing and treating complex neurological disorders.
• Owned Research Site Network Company-owned clinical research sites in Houston (TX), McAllen (TX), Lake Charles (LA), Gurnee (IL), Rockville (MD), and Wichita (KS), providing access to diverse patient populations across family medicine, endocrinology, cardiovascular/metabolic/renal, gastroenterology, neurology, pulmonology, women's health, and other therapeutic areas.

Quantifiable outcome

• 125% of enrollment target achieved on migraine trial using partner technology

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

One partnership is on record.

• CRIOcoreTechnology or Integration · 15 July 2024Elevate Clinical Research joined CRIO's Partners Program, providing data entry and site operations services to CRIO-powered clinical research sites. Elevate's global staff enters source data into the EDC daily with most site visits entered overnight, resolving 60-90% of queries same-day. They also provide weekly metrics, source QC review, and coordinator training.

Scale indicators3 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• Medpace: Mid-to-large CRO with strong sponsor relationships and centralized site management functions, frequently competing for the same Phase 1–4 studies Elevate targets.
• WCG Clinical: Provider of clinical trial site activation, IRB, and technology services used by sponsors, CROs, and sites. Adjacent infrastructure layer that Elevate's regulatory and site activation services partially overlap with.
• IQVIA: Largest global CRO/SMO with deep sponsor relationships, dedicated site network, and significant bargaining power on study awards. Represents the dominant competitor Elevate must differentiate against.
• ICON plc: Global CRO (formed via PRA Health Sciences combination) with site and patient access capabilities. Sets the bar for sponsor expectations around scale and operational metrics.

Others

• CRIO: eRegulatory and EDC platform provider for clinical research sites. Directly comparable as the technology backbone Elevate has integrated, and serves the same site-operator customer base.

Direct peers

• Flourish Research: Multi-specialty clinical research site network operating across multiple US states with therapeutic breadth similar to Elevate. Competes for the same sponsor study awards.
• Elligo Health Research: SMO that combines owned sites, partner physician practices, and decentralized trial operations to serve sponsors and CROs. Closely mirrors Elevate's hybrid owned + JV + decentralized model.
• Javara: Integrated clinical research organization partnering with healthcare practices and academic systems to embed trials, with an analogous focus on operationalizing existing clinical sites for sponsor trials.
• Velocity Clinical Research: Multi-site SMO operating owned and affiliated clinical trial sites across the US with similar therapeutic breadth and sponsor-facing services. Most directly comparable business model to Elevate's owned-and-partner site network.

Emerging players

• Clincierge: Patient logistics and concierge services for clinical trial participants, comparable to Elevate's emphasis on recruitment and patient-retention services for sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/elevateclinical
• LinkedInlinkedin.com/company/elevate-clinical
• Instagraminstagram.com/elevateclinical

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elevate Clinical Research